Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan

• by Ruba Al Abweh, Sarah Al Sharie, Nabil Hasasna, Nisreen Amayiri, Mouness Obeidat, Maysa Al-Hussaini

• July 17, 2026

Spinal metastases in geriatric patients: a retrospective single-center comparison of mortality and surgical outcomes following neurosurgical treatment

• by Saif-Eldin Abedellatif, Marija Janjic, Logman Khalafov, Harun Asoglu, Juliane Dittmer, Haitham Alenezi, Ivan Maiseyeu, Mohammed Jaber, Muriel Heimann, Tim Lampmann, Matthias Schneider, Hartmut Vatter, Motaz Hamed, Mohammed Banat

• July 16, 2026

Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab

• by Mayara Elisa Bonatto, Jan Dvořák, Marek Kollár, David Girsa, Miroslav Průcha, Šárka Forejtová, Heřman Mann, Jiří Vencovský, Karel Pavelka, Ladislav Šenolt

• July 15, 2026

Surviving CGT's Funding Winter

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market

• by Alun Evans, James Strachan

• July 15, 2026

• 11 min